PreprintCited by 5Connexins and lens biologyAmyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Insulin docking within the open hemichannel of connexin 43 may reduce risk of amyotrophic lateral sclerosis

Open access

Preprint — published as 10.21873/invivo.13112 · Paper page

Abstract

Background: Type 2 diabetes (T2D), characterized by hyperinsulinemia, protects motor neurons against amyotrophic lateral sclerosis (ALS). Type 1 diabetes and a total lack of insulin are associated with increased risk of ALS. Connexin 43 (Cx43), an astrocyte protein, operates as an open pore via which toxic substances from the astrocytes reach the motor neurons. Methods: In the current study we performed molecular docking of insulin with monomeric Cx31, monomeric Cx43, and hexameric Cx31 to assess whether insulin might affect the pore. Hexameric Cx31 and hexameric Cx43 have hemichannels composed of 6 subunits that work as transmembrane channels, binding together to form gap junction intercellular channels that open and close. We used the program AutoDock Vina Extended for the molecular docking study. Results: Cx31 shares amino acid and structural similarity to Cx43 and insulin docks to the same position of the N-terminal domain of monomeric Cx31 and monomeric Cx43. Insulin docks within the open hemichannel of hexameric Cx31, potentially blocking it. The block may be responsible for the protective relationship of T2D to ALS. Conclusion: Insulin, especially intranasal insulin, might be a treatment for ALS. An insulin secretogogue such as oral sulfonylurea or glinide might also be of value.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2022.05.06.490928

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 20

  1. 2015, Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study, JAMA Neurol, 72, 905, 10.1001/jamaneurol.2015.0910 · DOI · Paper page
  2. 10.1111/ene.12632 · DOI · Paper page
  3. 2018, The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis, Eur J Neurol, 25, 164, 10.1111/ene.13465 · DOI · Paper page
  4. 2022, Association between type 2 diabetes and amyotrophic lateral sclerosis, Sci Rep, 12, 2544, 10.1038/s41598-022-06463-6 · DOI
  5. 2022, Cx43 hemichannels contribute to astrocyte-mediated toxicity in sporadic and familial ALS, Proc Natl Acad Sci U S A, 119, e2107391119, 10.1073/pnas.2107391119 · DOI
  6. Hawat G , Baroudi G (2012) Connexin 43 Hemichannels and Pharmacotherapy of Myocardial Ischemia Injury In Novel Strategies in Ischemic Heart Disease IntechOpen. · DOI
  7. 10.1126/sciadv.aba4996 · DOI
  8. 10.2337/diabetes.49.12.2094 · DOI
  9. 10.1002/jcc.21334 · DOI · Paper page
  10. 10.1002/jcc.20084 · DOI
  11. Komaroff AL (2021) Breakthrough Discovery in Protein Structure Prediction and the Promise of New Treatments. JAMA. · DOI
  12. 2017, The ClusPro web server for protein–protein docking, Nature protocols, 12, 255, 10.1038/nprot.2016.169 · DOI
  13. 2013, How good is automated protein docking?, Proteins: Structure, Function, and Bioinformatics, 81, 2159, 10.1002/prot.24403 · DOI
  14. 2001, Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex, Acta Neuropathol, 101, 449, 10.1007/s004010000305 · DOI
  15. Qi C , Acosta-Gutierrez S , Lavriha P , Othman A , Lopez-Pigozzi D , Bayraktar E , Schuster D , Picotti P , Zamboni N , Bortolozzi M (2022) Structure of the connexin-43 gap junction channel reveals a closed sieve-like molecular gate. bioRxiv. · DOI
  16. 10.1073/pnas.1000002107 · DOI
  17. 10.1038/nn849 · DOI · Paper page
  18. 10.1212/WNL.50.1.164 · DOI · Paper page
  19. 2020, GJA1 Gene Polymorphisms and Topographic Distribution of Cranial MRI Lesions in Cerebral Small Vessel Disease, Front Neurol, 11, 583974, 10.3389/fneur.2020.583974 · DOI
  20. 2021, Expanding the clinical phenotype associated with NIPAL4 mutation: Study of a Tunisian consanguineous family with erythrokeratodermia variabilis-Like Autosomal Recessive Congenital Ichthyosis, PLoS One, 16, e0258777, 10.1371/journal.pone.0258777 · DOI

Metadata

Authors
Lehrer, S., & Rheinstein, P. H.
Corresponding author
Lehrer, Steven
Venue
In Vivo
Publisher
openRxiv
Published
2022-05-06
Volume
37
Issue
2
Pages
539-547
ISSN
0258-851X (ISSN-L)
OpenAlex
W4323347484
Cited by
5
References
1
Citations by year
2024: 3 · 2023: 2
FWCI
0.45
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • In Vivo (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (1s10od026880-01)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connexins and lens biology
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
insulin, amyotrophic lateral sclerosis, connexin 43, connexin 31, gap junctions, type 2 diabetes, motor neuron protection, intranasal insulin, sulfonylureas, meglitinides, insulin secretagogues
MeSH terms
Amyotrophic Lateral Sclerosis, Diabetes Mellitus, Type 2, Humans, Insulin, Connexin 43, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin docking within the open hemichannel of connexin 43 may reduce risk of amyotrophic lateral sclerosis. https://app.cochat.ai/papers/10.1101/2022.05.06.490928
The paper
Lehrer, S., & Rheinstein, P. H. (2022). Insulin docking within the open hemichannel of connexin 43 may reduce risk of amyotrophic lateral sclerosis. In Vivo. https://doi.org/10.1101/2022.05.06.490928